JP2008125642A - Drug administration device - Google Patents

Drug administration device Download PDF

Info

Publication number
JP2008125642A
JP2008125642A JP2006312030A JP2006312030A JP2008125642A JP 2008125642 A JP2008125642 A JP 2008125642A JP 2006312030 A JP2006312030 A JP 2006312030A JP 2006312030 A JP2006312030 A JP 2006312030A JP 2008125642 A JP2008125642 A JP 2008125642A
Authority
JP
Japan
Prior art keywords
movable wall
drug
storage chamber
housing chamber
wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006312030A
Other languages
Japanese (ja)
Inventor
Mitsuru Kobayashi
充 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Electric Works Co Ltd
Original Assignee
Matsushita Electric Works Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Works Ltd filed Critical Matsushita Electric Works Ltd
Priority to JP2006312030A priority Critical patent/JP2008125642A/en
Priority to PCT/JP2007/071513 priority patent/WO2008059728A1/en
Publication of JP2008125642A publication Critical patent/JP2008125642A/en
Withdrawn legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drug administration device for surely administering a drug to a desired site to be dosed. <P>SOLUTION: The drug administration device A is equipped with: a drug administration device main body 1 supplied into a celom; a housing chamber 3 provided inside the drug administration device main body 1; a movable wall 5 formed of a permanent magnet and freely movably disposed inside the housing chamber 3; a drug housing chamber 3a which houses an administration drug 8 and is composed of a space surrounded by the inner wall of the housing chamber 3 and the movable wall 5 while the movable wall 5 is moved to one end side of a moving range; a drug administering port 6 provided on the other end side of the moving range of the movable wall 5 in the housing chamber 3 and for communicating the housing chamber 3 with the outside; a sealing plug 7 fitted to the drug administering port 6 in a clearance fit condition; spiral coils 9 and 10 formed on both side walls (the surface 2a of a fixed wall 2 and the inner surface 1a of the drug administration device main body 1) of the moving range of the movable wall 5 in the housing chamber 3 by using the technique of manufacturing a three-dimensional solid circuit board; and an excitation circuit 31 for energizing the coils 9 and 10 in accordance with trigger input and generating electromagnetic force for moving the movable wall 5 to the other end side of the moving range. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、投薬装置に関するものである。   The present invention relates to a dispensing device.

この種の投薬装置としては、体腔内を観察するための観察手段などの各種の構成部材が筐体内部に配設された本体ユニットと、薬剤を収容しこの収容した薬剤の放出機構を備えた薬剤ユニットとで構成される医療用カプセル装置が従来提案されている(例えば特許文献1参照)。   This type of dispensing device includes a main unit in which various components such as observation means for observing the inside of a body cavity are disposed inside the housing, and a mechanism for storing the drug and storing the stored drug. A medical capsule device composed of a drug unit has been conventionally proposed (see, for example, Patent Document 1).

上記特許文献に開示された医療用カプセル装置では、薬剤ユニットに、内部に充填されている薬剤を外部へと放出し噴射するための噴射ノズルと、薬剤を押し出して噴射ノズルから外部に噴射させる放出機構とを設け、この噴射ノズルの噴射口を体腔内で溶解する成分で形成された溶解性膜で閉塞している。   In the medical capsule device disclosed in the above-mentioned patent document, an ejection nozzle for ejecting and ejecting a medicine filled in the medicine unit to the outside and an ejection for pushing the medicine and ejecting the medicine to the outside from the medicine unit The injection port of this injection nozzle is closed with a soluble film formed of a component that dissolves in the body cavity.

この医療用カプセル装置を用いて体腔内の所望の部位に投薬したい場合、薬剤を内部に充填して噴射ノズルの噴射口を溶解性膜で覆った薬剤ユニットと、本体ユニットとを結合した状態の医療用カプセル装置を被験者が嚥下すると、医療用カプセル装置が被験者の体腔内をその蠕動運動によって移動する。薬剤ユニットの噴射口を覆う溶解性膜は体腔内で溶解される成分で形成されているので、被験者が嚥下すると同時に溶解が開始され、やがて噴射口が開放された状態となる。そして、医療用カプセル装置が体腔内の投薬部位に移動した時点で、本体ユニットに投薬指令を送信すると、本体ユニットが薬剤ユニットの放出機構を作動させて、薬剤ユニットの内部に充填された薬剤を外部(体腔内)に噴射させるようになっている。
特開2005−185536号公報(段落番号[0017]−[0033]、[0038]−[0040]、及び、第1図)
When it is desired to administer a desired site in a body cavity using this medical capsule device, the drug unit in which the drug is filled and the spray nozzle is covered with a soluble film is combined with the main unit. When the subject swallows the medical capsule device, the medical capsule device moves in the body cavity of the subject by its peristaltic motion. Since the dissolvable film covering the injection port of the drug unit is formed of a component that is dissolved in the body cavity, dissolution starts as soon as the subject swallows, and eventually the injection port is opened. When the medical capsule device moves to the dosing site in the body cavity and sends a medication command to the main body unit, the main body unit activates the release mechanism of the medicinal unit so that the medicine filled in the medicinal unit is loaded. It is designed to be ejected outside (inside the body cavity).
JP 2005-185536 A (paragraph numbers [0017]-[0033], [0038]-[0040] and FIG. 1)

上述の医療用カプセル装置では、薬剤ユニットの噴射口が体腔内で溶解される溶解性膜で覆われているので、この溶解性膜が溶解されて噴射口が開放された状態となるまでの時間に個人差が発生し、所望の投薬部位に到達する前に薬剤が漏れだしたり、投薬部位に到達しても溶解性膜が全て溶解されていないために、投薬部位に全ての薬剤を投薬できない可能性もあった。   In the above-described medical capsule device, since the injection port of the drug unit is covered with a soluble film dissolved in the body cavity, the time until the soluble film is dissolved and the injection port is opened. Because there are individual differences, the drug leaks before reaching the desired dosing site, or all of the soluble film is not dissolved when the dosing site is reached, so it is not possible to dispense all the drugs at the dosing site There was also a possibility.

本発明は上記問題点に鑑みて為されたものであり、その目的とするところは、所望の投薬部位に確実に投薬できる投薬装置を提供することにある。   The present invention has been made in view of the above-described problems, and an object of the present invention is to provide a dosing device that can reliably dispense a desired dosing site.

上記目的を達成するために、請求項1の発明は、体腔内に投入される投薬装置本体と、投薬装置本体の内部に設けられた収容室と、永久磁石により形成されて収容室の内部に移動自在に配置される可動壁と、可動壁が移動範囲の一端側に移動した状態で収容室の内壁と可動壁とで囲まれる空間からなり、投薬用の薬剤を収容する薬剤収容室と、収容室において可動壁の移動範囲の他端側に設けられ収容室と外部とを連通する投薬口と、投薬口に遊動嵌合された封止栓と、収容室において可動壁の移動範囲の両側壁に3次元立体回路基板の製造技術を用いて形成された渦巻き状のコイルと、トリガ入力に応じてコイルに電力を供給し、可動壁を移動範囲の他端側へ移動させるような電磁力を発生させる励磁手段とを備えて成ることを特徴とする。   In order to achieve the above object, the invention of claim 1 is characterized in that a dosing device body to be put into a body cavity, a storage chamber provided in the dosing device body, and a permanent magnet are formed in the storage chamber. A movable wall that is movably disposed, and a space that is surrounded by the inner wall and the movable wall of the storage chamber in a state in which the movable wall is moved to one end side of the moving range, and a drug storage chamber that stores a medicine for medication, A dispensing port provided at the other end of the movable range of the movable wall in the storage chamber and communicating the storage chamber with the outside, a sealing plug loosely fitted to the dispensing port, and both sides of the movable range of the movable wall in the storage chamber A spiral coil formed using 3D circuit board manufacturing technology on the wall and an electromagnetic force that moves the movable wall to the other end of the moving range by supplying power to the coil in response to a trigger input And excitation means for generating

請求項2の発明は、請求項1の発明において、封止栓がコイルに発生するジュール熱で溶解可能な材料により形成されており、コイルの一部を投薬口の近傍に形成したことを特徴とする。   The invention of claim 2 is characterized in that, in the invention of claim 1, the sealing plug is made of a material that can be dissolved by Joule heat generated in the coil, and a part of the coil is formed in the vicinity of the dosing port. And

請求項1の発明によれば、励磁手段がトリガ入力を受けてコイルに電力を供給しており、コイルが発生する電磁力により、永久磁石からなる可動壁が移動範囲の他端側へ移動させられるので、可動壁が移動範囲の他端側へ移動することによって、薬剤収容室の内部の圧力を増加させ、投薬口に遊動嵌合された封止栓を外部に押し出して投薬口を開口させるとともに、薬剤収容室に収容された薬剤を投薬口を通して外部(体腔内)に投入させることができるという効果がある。したがって、投薬口を塞ぐ封止栓が、薬剤の投入位置に到達するよりも前に外れることはないから、投入位置よりも前に薬剤が漏れ出すことはなく、しかも投入位置に到達した時点で封止栓が外れて投薬口が確実に開放されるから、薬剤をスムーズに投与できるという効果もある。   According to the first aspect of the present invention, the exciting means receives the trigger input and supplies electric power to the coil, and the movable wall made of the permanent magnet is moved to the other end side of the moving range by the electromagnetic force generated by the coil. Therefore, when the movable wall moves to the other end side of the moving range, the pressure inside the drug storage chamber is increased, and the sealing plug loosely fitted to the medication port is pushed out to open the medication port. In addition, there is an effect that the medicine accommodated in the medicine accommodating chamber can be introduced to the outside (inside the body cavity) through the medication port. Therefore, since the sealing plug that closes the dosing port does not come off before reaching the loading position of the drug, the drug does not leak before the loading position, and when it reaches the loading position Since the sealing plug is removed and the dosing port is reliably opened, there is an effect that the medicine can be administered smoothly.

請求項2の発明によれば、励磁手段がコイルに通電した際にコイルに発生するジュール熱で封止栓を溶解させることによって、封止栓と投薬口とのはめあいを緩めて、封止栓を外れ易くできるという効果がある。したがって、封止栓が溶解される前のはめあいをきつめにでき、封止栓と投薬口との間のすきまから薬剤が漏れ出るのを抑制できるという効果もある。   According to the invention of claim 2, the sealing plug is melted by Joule heat generated in the coil when the excitation means energizes the coil, thereby loosening the fit between the sealing plug and the medication port. There is an effect that can be easily removed. Therefore, the fit before the sealing plug is dissolved can be tight, and there is also an effect that the medicine can be prevented from leaking from the gap between the sealing plug and the medication port.

以下に本発明の実施の形態を図1〜図6に基づいて説明する。   Embodiments of the present invention will be described below with reference to FIGS.

図1は本実施形態の投薬装置Aの概略断面図であり、この投薬装置Aは、例えばセラミックやポリエーテルエーテルケトン(PEEK)などの耐熱性を有する材料によりカプセル形状に形成された投薬装置本体1を備えている。   FIG. 1 is a schematic cross-sectional view of a dosing device A according to the present embodiment. This dosing device A is a main body of a dosing device formed in a capsule shape from a heat-resistant material such as ceramic or polyether ether ketone (PEEK). 1 is provided.

投薬装置本体1の内部は、長手方向の中間部に設けた固定壁2によって左右2つの収容室3,4に仕切られている。また、図中左側の収容室3には、収容室3の断面よりもやや小さい平面形状に形成された永久磁石からなる可動壁5が、収容室3の長手方向において移動自在に配置されている。   The inside of the prescription device main body 1 is divided into two left and right accommodation chambers 3 and 4 by a fixed wall 2 provided at an intermediate portion in the longitudinal direction. Further, in the storage chamber 3 on the left side in the drawing, a movable wall 5 made of a permanent magnet formed in a planar shape slightly smaller than the cross section of the storage chamber 3 is disposed so as to be movable in the longitudinal direction of the storage chamber 3. .

ここで、収容室3の内壁と、可動壁5における固定壁2と反対側の壁面とで囲まれる空間から、投薬用の薬剤8を収容する薬剤収容室3aが形成されている。また投薬装置本体1には、長手方向において対向する両端部の内、収容室3側の端部に薬剤収容室3aと外部とを連通する投薬口6が形成されている。そして、投薬口6には、体腔内の温度よりも高温の所定温度(例えば40〜45℃)で溶解される材料(例えば牛脂など)から形成された封止栓7が、すきまばめの状態で外部より嵌入(遊動嵌合)されている。なお、投薬装置本体1には、可動壁5と固定壁2の間の空間と外部を連通する空気抜き用の開口孔(図示せず)が形成されている。   Here, from a space surrounded by the inner wall of the storage chamber 3 and the wall surface of the movable wall 5 on the side opposite to the fixed wall 2, a drug storage chamber 3 a for storing the medication 8 is formed. Also, the medication apparatus body 1 is formed with a medication port 6 that communicates the medicine storage chamber 3a with the outside at the end on the side of the storage chamber 3 among the opposite ends in the longitudinal direction. A sealing plug 7 made of a material (for example, beef tallow) that is dissolved at a predetermined temperature (for example, 40 to 45 ° C.) higher than the temperature in the body cavity is in the dosing port 6 in a state of clearance fit. Is inserted from the outside (floating fitting). The dosing device main body 1 is formed with an air vent opening hole (not shown) for communicating the space between the movable wall 5 and the fixed wall 2 with the outside.

一方、収容室3を囲む壁の内、投薬装置本体1の長手方向一端側の内面1aと、固定壁2における収容室4側の表面2aには、後述する3次元立体回路基板の製造技術を用いて渦巻き状のコイル9,10が形成されている。   On the other hand, on the inner surface 1a on one end side in the longitudinal direction of the prescription device main body 1 and the surface 2a on the storage chamber 4 side of the fixed wall 2 among the walls surrounding the storage chamber 3, a manufacturing technique for a three-dimensional circuit board described later is applied. The spiral coils 9 and 10 are formed by using them.

図3は固定壁2の表面2aに形成されたコイル9の概略形状を示し、コイル9の外周側の端部は後述のバッテリ34が接続される端子9aとなり、内周側の端部はスルーホール2bを介して裏面に形成された導電パターン11に電気的に接続されている。この導電パターン11は、収容室3の頂部に長手方向に沿って形成された金属めっき層からなる導電部12の一端側に電気的に接続されており、導電部12の他端側は投薬装置本体1の長手方向一端面に設けたスルーホール1bを介して、投薬装置本体1の外面に形成された導電パターン13に電気的に接続されている。また導電パターン13は、投薬装置本体1の長手方向一端部の外面において外周側から中心側にかけて形成されており、中心側の端部は投薬装置本体1の長手方向一端部に設けたスルーホール1cを介して、投薬装置本体1の内面1aに形成されたコイル10の内周側の端部に電気的に接続されている。コイル10はコイル9と同様に渦巻き状に形成されており、コイル10の外周側の端部は収容室3の底部に長手方向に沿って形成された金属メッキ層からなる導電部14に接続されている。また固定壁2の表面2aには、導電部14に電気的に接続される端子15が形成されており、この端子15と端子9aの間にコイル9,10が直列に接続されているのである。なお、投薬装置本体1の外側面に設けた導電パターン13は図示しない絶縁層によって覆われており、絶縁が確保されている。   FIG. 3 shows a schematic shape of the coil 9 formed on the surface 2a of the fixed wall 2. The outer end of the coil 9 serves as a terminal 9a to which a battery 34 described later is connected, and the inner end is a through-hole. It is electrically connected to the conductive pattern 11 formed on the back surface through the hole 2b. The conductive pattern 11 is electrically connected to one end side of a conductive portion 12 made of a metal plating layer formed along the longitudinal direction on the top of the storage chamber 3, and the other end side of the conductive portion 12 is a dosing device. It is electrically connected to a conductive pattern 13 formed on the outer surface of the prescription device main body 1 through a through hole 1b provided on one end surface in the longitudinal direction of the main body 1. The conductive pattern 13 is formed from the outer peripheral side to the center side on the outer surface of one end portion in the longitudinal direction of the dosing device body 1, and the end on the center side is a through hole 1 c provided at one end portion in the longitudinal direction of the dosing device body 1. Is electrically connected to the inner peripheral end of the coil 10 formed on the inner surface 1a of the dosing device body 1. The coil 10 is formed in a spiral shape like the coil 9, and the end portion on the outer peripheral side of the coil 10 is connected to a conductive portion 14 made of a metal plating layer formed along the longitudinal direction at the bottom of the storage chamber 3. ing. Further, a terminal 15 electrically connected to the conductive portion 14 is formed on the surface 2a of the fixed wall 2, and the coils 9 and 10 are connected in series between the terminal 15 and the terminal 9a. . In addition, the conductive pattern 13 provided on the outer surface of the prescription device main body 1 is covered with an insulating layer (not shown) to ensure insulation.

一方、投薬装置本体1の右側の収容室4には、トリガ入力を受けて投薬動作を行わせるための制御回路30が収納されている。制御回路30は、端子9a,15間にバッテリ34を介して接続されるスイッチ素子(図示せず)を備え、スイッチ素子のオン/オフを制御することによってコイル9,10への通電をオン/オフする励磁回路31(励磁手段)と、被験者の体外に設けた遠隔操作装置(図示せず)との間でアンテナ33を介して電波信号を送受信する送受信回路32と、投薬装置本体1の外部の映像を撮像するカメラ35とを備える。送受信回路32は、所定の時間間隔でカメラ35から入力される画像データを電波信号により外部の遠隔操作装置へ送信するとともに、遠隔操作装置から電波信号で送信された投薬指令を受信すると、受信した投薬指令を励磁回路31に出力する。励磁回路31では、送受信回路32から投薬指令(トリガ入力)が与えられると、スイッチ素子をオンさせ、バッテリ34の直流電圧をコイル9,10に印加することで、コイル9,10に磁界を発生させる。この時、コイル9には可動壁5の磁極と反発するような磁界が発生するとともに、コイル10には可動壁5の磁極を吸引するような磁界が発生するように、各コイル9,10の巻き方および励磁電流の方向が設定されているので、コイル9,10に発生した磁界によって、可動壁5が収容室3内の移動範囲を一端側(図1中右側)から他端側(左側)へ移動させられるのである。   On the other hand, in the storage chamber 4 on the right side of the prescription device main body 1, a control circuit 30 for receiving a trigger input and performing a prescription operation is stored. The control circuit 30 includes a switch element (not shown) connected between the terminals 9a and 15 via the battery 34, and controls on / off of the switch element to turn on / off the energization of the coils 9, 10. A transmission / reception circuit 32 for transmitting and receiving radio signals via an antenna 33 between an excitation circuit 31 (excitation means) to be turned off and a remote control device (not shown) provided outside the body of the subject, and the outside of the prescription device main body 1 And a camera 35 that picks up images of the above. The transmission / reception circuit 32 transmits the image data input from the camera 35 at a predetermined time interval to the external remote control device by a radio wave signal, and receives the medication command transmitted from the remote control device by the radio signal. A medication command is output to the excitation circuit 31. In the excitation circuit 31, when a medication command (trigger input) is given from the transmission / reception circuit 32, the switch element is turned on, and the DC voltage of the battery 34 is applied to the coils 9, 10 to generate a magnetic field in the coils 9, 10. Let At this time, a magnetic field that repels the magnetic pole of the movable wall 5 is generated in the coil 9, and a magnetic field that attracts the magnetic pole of the movable wall 5 is generated in the coil 10. Since the winding method and the direction of the excitation current are set, the movable wall 5 moves the moving range in the storage chamber 3 from one end side (right side in FIG. 1) to the other end side (left side) by the magnetic field generated in the coils 9 and 10. ).

投薬装置Aは以上のような構成を有しており、本実施形態の投薬装置Aを用いて被験者の体腔内に薬剤を投与する方法について以下に説明する。   The dosing device A has the above-described configuration, and a method for administering a drug into the body cavity of a subject using the dosing device A of the present embodiment will be described below.

投薬装置本体1の収容室3内で可動壁5を固定壁2側に移動させた状態で、収容室3の内壁と可動壁5とで囲まれる薬剤収容室3aに投薬口6から薬剤を充填した後、投薬口6に封止栓7を嵌着させて、投薬口6を閉塞する(図1参照)。   In the state where the movable wall 5 is moved to the fixed wall 2 side in the storage chamber 3 of the prescription device main body 1, the drug storage chamber 3 a surrounded by the inner wall of the storage chamber 3 and the movable wall 5 is filled with the drug from the prescription port 6. Thereafter, the sealing plug 7 is fitted into the dosing port 6 to close the dosing port 6 (see FIG. 1).

この投薬装置本体1を被験者が嚥下すると、投薬装置本体1は被験者の体腔内をその蠕動運動によって移動する。投薬装置本体1では、カメラ35の画像を一定の時間間隔で外部の遠隔操作装置へ送信しており、遠隔操作装置側でモニタにカメラ35の画像を表示させることで、投薬担当者が投薬装置本体1の現在位置を把握できるようになっている。したがって、投薬担当者が、遠隔操作装置のモニタ画像をもとに投薬装置本体1が投薬位置に到達したことを確認すると、遠隔操作装置を操作して投薬指令を無線信号により送信させる。   When the subject swallows the medication device body 1, the medication device body 1 moves in the body cavity of the subject by its peristaltic motion. In the medication apparatus main body 1, images of the camera 35 are transmitted to an external remote control device at regular time intervals, and by displaying the image of the camera 35 on the monitor on the remote control device side, the medication person in charge can display the image of the camera 35. The current position of the main body 1 can be grasped. Therefore, when the person in charge of medication confirms that the medication device main body 1 has reached the medication position based on the monitor image of the remote control device, the medication operator is operated to transmit a medication command by a radio signal.

この時、投薬装置本体1では、送受信回路32により受信された投薬指令が励磁回路31に入力され、励磁回路31が図示しないスイッチ素子をオンさせて、バッテリ34の直流電圧をコイル9,10に印加させ、コイル9,10により磁界を発生させる。ここで、コイル9には、可動壁5を構成する永久磁石の磁極と反発するような磁界が発生し、コイル10には、可動壁5を構成する永久磁石の磁極を吸引するような磁界が発生するので、コイル9,10の磁界により可動壁5を図1中の左側に移動させるような電磁力が発生する。   At this time, in the medication apparatus main body 1, the medication command received by the transmission / reception circuit 32 is input to the excitation circuit 31, and the excitation circuit 31 turns on a switch element (not shown) so that the DC voltage of the battery 34 is applied to the coils 9 and 10. The magnetic field is generated by the coils 9 and 10. Here, a magnetic field that repels the magnetic pole of the permanent magnet that constitutes the movable wall 5 is generated in the coil 9, and a magnetic field that attracts the magnetic pole of the permanent magnet that constitutes the movable wall 5 is generated in the coil 10. Therefore, an electromagnetic force that moves the movable wall 5 to the left in FIG. 1 is generated by the magnetic field of the coils 9 and 10.

この電磁力を受けて可動壁5が図1中の左側へ移動しようとすると、薬剤収容室3a内に収容された薬剤8が圧縮されて、内部の圧力が上昇し、この圧力上昇によって投薬口6に遊嵌された封止栓7が外側に押し出され、投薬口6が開放される。その後、可動壁5が投薬装置本体1の長手方向一端側の端部付近まで移動すると、可動壁5の移動に伴い、薬剤収容室3aに収容された薬剤8が投薬口6から外部(体腔内)に押し出されるのである(図2参照)。   When the movable wall 5 receives the electromagnetic force and moves to the left side in FIG. 1, the medicine 8 accommodated in the medicine accommodating chamber 3a is compressed, and the internal pressure rises. The sealing plug 7 loosely fitted to 6 is pushed outward, and the medication port 6 is opened. Thereafter, when the movable wall 5 moves to the vicinity of the end on one end side in the longitudinal direction of the medication apparatus body 1, the medicine 8 accommodated in the medicine accommodation chamber 3 a is moved from the medication port 6 to the outside (inside the body cavity) with the movement of the movable wall 5. ) (See FIG. 2).

なお封止栓7は、投薬口6の周囲に形成されたコイル10に発生するジュール熱で溶解可能な牛脂(融点が40〜45)などの材料で形成されているので、コイル10に通電した際に封止栓7の表面が溶解することで、封止栓7と投薬口6とのはめあいが緩くなって、封止栓7を外れ易くしている。したがって、封止栓7が溶解される前のはめあいをきつめに設定することができ、封止栓7と投薬口6との間のすきまから漏れ出す薬剤8を低減することができる。   Since the sealing plug 7 is formed of a material such as beef tallow (melting point: 40 to 45) that can be dissolved by Joule heat generated in the coil 10 formed around the dosing port 6, the coil 10 is energized. At this time, the surface of the sealing plug 7 is dissolved, so that the fit between the sealing plug 7 and the dosing port 6 is loosened so that the sealing plug 7 can be easily detached. Therefore, the fit before the sealing plug 7 is dissolved can be set tightly, and the drug 8 leaking from the gap between the sealing plug 7 and the medication port 6 can be reduced.

このように、本実施形態では、投薬担当者が被験者の体腔外にある遠隔操作装置を用いて投薬指令を送信させた時点で、投薬装置Aが、コイル9,10に通電して可動壁5を移動させることで、投薬動作を行わせているので、封止栓7を押し出して薬剤8を放出するタイミングのばらつきが少なく、投薬のタイミングを厳密に制御して、所望の投薬部位に確実に薬剤を投与することができる。またコイル9,10に発生する磁界で可動壁5を駆動しているので、ほぼ一定の力で可動壁5を駆動することができ、投薬口6からほぼ一定の流速で薬剤8を放出することができる。   Thus, in this embodiment, when the person in charge of medication sends a medication command using the remote control device outside the body cavity of the subject, the medication device A energizes the coils 9 and 10 to move the movable wall 5. Since the dispensing operation is performed by moving the, the variation in the timing of pushing out the sealing plug 7 to release the drug 8 is small, and the timing of dosing is strictly controlled to ensure the desired dosing site. A drug can be administered. Further, since the movable wall 5 is driven by the magnetic field generated in the coils 9 and 10, the movable wall 5 can be driven with a substantially constant force, and the drug 8 is released from the medication port 6 at a substantially constant flow rate. Can do.

ところで、上述のコイル9,10は3次元立体回路基板の製造技術を用いて形成されるのであるが、その製造技術について図4〜図6を参照して説明する。   By the way, although the above-mentioned coils 9 and 10 are formed using the manufacturing technique of a three-dimensional three-dimensional circuit board, the manufacturing technique is demonstrated with reference to FIGS.

図4は3次元立体回路基板の製造方法の概要を示すフローである。3次元立体回路基板は、樹脂材料を射出成型することで所望の三次元形状の基板21を成型する成型工程(S1)、基板21の表面にスパッタリング、蒸着、イオンプレーティングなどの物理蒸着法による導電性薄膜22の成膜を行うメタライズ処理工程(S2)、高エネルギービーム(本実施形態ではレーザビーム)による回路部/非回路部の分離を行うレーザ処理工程(S3)、回路部のめっきによる厚膜化を行ってめっき層23を形成するめっき処理工程(S4)、非回路部のエッチング処理工程(S5)の各工程を順次実施することで製造される。   FIG. 4 is a flowchart showing an outline of a method for manufacturing a three-dimensional circuit board. The three-dimensional three-dimensional circuit board is formed by a molding process (S1) in which a resin material is injection-molded to mold a desired three-dimensional substrate 21, and a physical vapor deposition method such as sputtering, vapor deposition, or ion plating on the surface of the substrate 21. A metallization process (S2) for forming the conductive thin film 22, a laser process (S3) for separating the circuit part / non-circuit part by a high energy beam (in this embodiment, a laser beam), and plating of the circuit part It is manufactured by sequentially performing each step of the plating process (S4) for forming the plating layer 23 by increasing the film thickness and the non-circuit part etching process (S5).

図5(a)〜(c)および図6(a)(b)は、上記各工程における3次元立体回路基板Bの表面処理の様子を示している。まず図5(a)は基板21の成型工程(S1)であり、絶縁性を有する合成樹脂を射出成形することによって、所望の三次元形状を有する基板21が成型される。ここにおいて基板21の成型材料としては、例えば熱可塑性樹脂の場合は芳香族ポリアミドや液晶性ポリエステルなどが、熱硬化性樹脂の場合はエポキシ樹脂や飽和ポリエステルなどが用いられ、またセラミックの場合は窒化アルミナなどが用いられる。また基板21の成型方法は射出成形に限らず、押出成型やトランスファ成型などの成型方法を用いても良い。   FIGS. 5A to 5C and FIGS. 6A and 6B show the surface treatment of the three-dimensional circuit board B in each of the above steps. First, FIG. 5A shows a molding step (S1) of the substrate 21, and the substrate 21 having a desired three-dimensional shape is molded by injection molding an insulating synthetic resin. Here, as the molding material of the substrate 21, for example, an aromatic polyamide or liquid crystalline polyester is used in the case of a thermoplastic resin, an epoxy resin or a saturated polyester is used in the case of a thermosetting resin, and a nitriding is used in the case of a ceramic. Alumina or the like is used. The molding method of the substrate 21 is not limited to injection molding, and a molding method such as extrusion molding or transfer molding may be used.

次に、図5(b)はメタライズ処理工程(S2)であり、例えば銅をターゲットとするスパッタリング、真空蒸着、イオンプレーティングなどの物理蒸着法(PVD法)によって、基板21の表面に導電性薄膜22が形成される。しかし、物理蒸着法に限定されることなく化学蒸着法などの他の方法で行ってもよい。導電性薄膜22は、銅以外に、ニッケル、金、アルミニウム、チタン、モリブデン、クロム、タングステン、スズ、鉛などの単体金属、又は黄銅、NiCrなどの合金を用いてもよい。   Next, FIG. 5B shows a metallization process step (S2). For example, the surface of the substrate 21 is made conductive by a physical vapor deposition method (PVD method) such as sputtering, vacuum deposition, or ion plating using copper as a target. A thin film 22 is formed. However, it may be performed by other methods such as a chemical vapor deposition method without being limited to the physical vapor deposition method. In addition to copper, the conductive thin film 22 may use a single metal such as nickel, gold, aluminum, titanium, molybdenum, chromium, tungsten, tin, or lead, or an alloy such as brass or NiCr.

図5(c)はレーザ処理工程(S3)であり、導電性薄膜22における回路部23aと非回路部23bとの境界部分に高エネルギービーム、例えば電磁波ビームであるレーザビームが照射され、その部分の導電性薄膜22が蒸発除去されて、その除去部23cによって回路部23aと非回路部23bとが分離され、所定の回路パターンが形成される。   FIG. 5C shows a laser processing step (S3). A boundary portion between the circuit portion 23a and the non-circuit portion 23b in the conductive thin film 22 is irradiated with a high energy beam, for example, a laser beam which is an electromagnetic wave beam. The conductive thin film 22 is removed by evaporation, and the circuit portion 23a and the non-circuit portion 23b are separated by the removal portion 23c to form a predetermined circuit pattern.

次に、図6(a)はめっき処理工程(S4)であり、回路部23aに給電されて電流が流れ、回路部23aの部分が例えば電解銅めっきにより厚膜化されて、めっき層24が形成される。このとき、非回路部23bには電流が流れず、非回路部23bの部分はめっきされないので、その膜厚はもとのままの薄膜の状態にある。尚、めっき層24としてはニッケル金めっきなどを形成しても良い。   Next, FIG. 6A is a plating process step (S4), in which power is supplied to the circuit portion 23a and current flows, and the portion of the circuit portion 23a is thickened by, for example, electrolytic copper plating. It is formed. At this time, no current flows through the non-circuit portion 23b, and the portion of the non-circuit portion 23b is not plated, so that the film thickness remains as it is. Note that nickel gold plating or the like may be formed as the plating layer 24.

次に、図6(b)はエッチング処理工程(S5)であり、回路パターン形成面全体をエッチングすることにより、非回路部23bが除去されて、回路パターンが形成された3次元回路基板が完成するのであり、このような製造技術を用いて、投薬装置本体1の一端部の内面1aや固定壁2の表面2aに渦巻き状のコイル9,10を形成することができるのである。   Next, FIG. 6B shows an etching process step (S5). By etching the entire circuit pattern forming surface, the non-circuit portion 23b is removed and a three-dimensional circuit board on which the circuit pattern is formed is completed. Therefore, the spiral coils 9 and 10 can be formed on the inner surface 1a of the one end portion of the dosing device body 1 and the surface 2a of the fixed wall 2 by using such a manufacturing technique.

なお、本発明の精神と範囲に反することなしに、広範に異なる実施形態を構成することができることは明白なので、この発明は、特定の実施形態に制約されるものではない。   It should be noted that a wide variety of different embodiments can be configured without departing from the spirit and scope of the present invention, and the present invention is not limited to a specific embodiment.

本実施形態の投薬装置の概略断面図である。It is a schematic sectional drawing of the medication apparatus of this embodiment. 同上の投薬後の状態を示す概略断面図である。It is a schematic sectional drawing which shows the state after dosing same as the above. 同上のコイルの概略構成を示す平面図である。It is a top view which shows schematic structure of a coil same as the above. 同上のコイルの製造方法の概要を示すフロー図である。It is a flowchart which shows the outline | summary of the manufacturing method of a coil same as the above. (a)〜(c)同上の各工程における表面処理の様子を示す斜視図である。(A)-(c) It is a perspective view which shows the mode of the surface treatment in each process same as the above. (a)(b)同上の各工程における表面処理の様子を示す斜視図である。(A) (b) It is a perspective view which shows the mode of the surface treatment in each process same as the above.

符号の説明Explanation of symbols

A 投薬装置
1 投薬装置本体
1a 内面
2 固定壁
2a 表面
3 収容室
3a 薬剤収容室
5 可動壁
6 投薬口
7 封止栓
8 薬剤
9,10 コイル
30 制御回路
31 励磁回路
A Dosing device 1 Dosing device body 1a Inner surface 2 Fixed wall 2a Surface 3 Storage chamber 3a Drug storage chamber 5 Movable wall 6 Dosing port 7 Seal plug 8 Drug 9, 10 Coil 30 Control circuit 31 Excitation circuit

Claims (2)

体腔内に投入される投薬装置本体と、投薬装置本体の内部に設けられた収容室と、永久磁石により形成されて前記収容室の内部に移動自在に配置される可動壁と、前記可動壁が移動範囲の一端側に移動した状態で前記収容室の内壁と可動壁とで囲まれる空間からなり、投薬用の薬剤を収容する薬剤収容室と、前記収容室において前記可動壁の移動範囲の他端側に設けられ収容室と外部とを連通する投薬口と、前記投薬口に遊動嵌合された封止栓と、前記収容室において前記可動壁の移動範囲の両側壁に3次元立体回路基板の製造技術を用いて形成された渦巻き状のコイルと、トリガ入力に応じて前記コイルに通電し、前記可動壁を移動範囲の他端側へ移動させるような電磁力を発生させる励磁手段とを備えて成ることを特徴とする投薬装置。   A dosing device body to be placed in a body cavity, a storage chamber provided inside the dosing device body, a movable wall formed by a permanent magnet and movably disposed inside the storage chamber, and the movable wall comprising: A space surrounded by the inner wall and the movable wall of the storage chamber in a state of moving to one end side of the movement range, a drug storage chamber for storing a medicine for medication, and the movement range of the movable wall in the storage chamber A three-dimensional three-dimensional circuit board on both side walls of the movable range of the movable wall in the accommodating chamber; a prescription opening provided on the end side and communicating with the outside of the accommodating chamber; A spiral coil formed by using the manufacturing technique, and excitation means for generating an electromagnetic force that energizes the coil in response to a trigger input and moves the movable wall to the other end side of the moving range. A dosing device comprising: 前記封止栓が前記コイルに発生するジュール熱で溶解可能な材料により形成されており、前記コイルの一部を前記投薬口の近傍に形成したことを特徴とする請求項1記載の投薬装置。   The dosing device according to claim 1, wherein the sealing plug is made of a material that can be dissolved by Joule heat generated in the coil, and a part of the coil is formed in the vicinity of the dosing port.
JP2006312030A 2006-11-17 2006-11-17 Drug administration device Withdrawn JP2008125642A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2006312030A JP2008125642A (en) 2006-11-17 2006-11-17 Drug administration device
PCT/JP2007/071513 WO2008059728A1 (en) 2006-11-17 2007-11-06 Capsule-type device for dispensing medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006312030A JP2008125642A (en) 2006-11-17 2006-11-17 Drug administration device

Publications (1)

Publication Number Publication Date
JP2008125642A true JP2008125642A (en) 2008-06-05

Family

ID=39552089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006312030A Withdrawn JP2008125642A (en) 2006-11-17 2006-11-17 Drug administration device

Country Status (1)

Country Link
JP (1) JP2008125642A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013501569A (en) * 2009-08-12 2013-01-17 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Chemical delivery device with compressible chemical reservoir
WO2019068136A1 (en) * 2017-10-03 2019-04-11 University Of Wollongong A device and a method for using a device to receive and/or deliver a substance in vivo
CN112968532A (en) * 2021-02-05 2021-06-15 浙江大学台州研究院 Wireless magnetic resistance actuator based on magnetic resonance coupling

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013501569A (en) * 2009-08-12 2013-01-17 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Chemical delivery device with compressible chemical reservoir
WO2019068136A1 (en) * 2017-10-03 2019-04-11 University Of Wollongong A device and a method for using a device to receive and/or deliver a substance in vivo
CN112968532A (en) * 2021-02-05 2021-06-15 浙江大学台州研究院 Wireless magnetic resistance actuator based on magnetic resonance coupling
CN112968532B (en) * 2021-02-05 2022-09-27 浙江大学台州研究院 Wireless magnetic resistance actuator based on magnetic resonance coupling

Similar Documents

Publication Publication Date Title
US11241562B2 (en) Ingestible device with relatively large payload volume
CN101346093B (en) Storage device for medical device, disposal device
US10780216B2 (en) Implantable medical device for minimally-invasive insertion
JP2008125642A (en) Drug administration device
CN106535677A (en) A container having a heater for an aerosol-generating device, and aerosol-generating device
US11865300B2 (en) Liquid medicine injection device
EP1804890B1 (en) Body-insertable apparatus for aspirating and expelling fluid
EP2237824A1 (en) Drug ejecting apparatus and control method thereof
CN100588378C (en) Alimentary tract drug release remote controlled capsule system
WO2011061985A1 (en) Power supply starter for capsule-type medical device
WO2008059728A1 (en) Capsule-type device for dispensing medicament
US8915904B2 (en) Implantable device with conforming telemetry coil and methods of making same
KR20220119113A (en) A vaporizer unit, vaporizer assembly and vaporizer cartridge for an inhaler, and method for producing an inhaler and vaporizer unit having such vaporizer cartridge
JP2006061399A (en) Examination capsule and examination system
JP2008125641A (en) Drug administration device
Hosseini Micro-electromechanical system based electronic capsules (MEMS) aimed at optimizing drug delivery to the human body
CN114099921B (en) In-vivo bending region explosion impact drug release energetic microsystem
JP2013078440A (en) Capsule-type endoscope
CN216983561U (en) Aerosol generating system and aerosol generating device
Lyutakov et al. Current advances in drug delivery systems for capsule endoscopy
WO2013051258A1 (en) Capsule endoscope
US20090105532A1 (en) In vivo imaging device and method of manufacturing thereof
WO2023281428A1 (en) A system for the controlled administration of a substance with an implantable infusion device provided with an improved docking group for reliably docking an ingestible substance carrier
KR20180026206A (en) Device for ejecting medical liquid
JP2018093887A (en) Capsule type medical device and storage container for capsule type medical device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080512

A761 Written withdrawal of application

Effective date: 20090423

Free format text: JAPANESE INTERMEDIATE CODE: A761